Open AccessLiver transplantation for hepatocellular carcinoma
Author(s) -
Sudeep Tanwar,
Shahid A. Khan,
Vijay Paul Bob Grover,
Catherine Gwilt,
Belinda Smith,
Ashley Brown
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.5511
Subject(s) - hepatocellular carcinoma , medicine , liver transplantation , milan criteria , malignancy , gastroenterology , chronic liver disease , liver cancer , liver disease , transplantation , survival rate , carcinoma , hepatocellular cancer , surgery , cirrhosis
Hepatocellular carcinoma (HCC) is the commonest primary malignancy of the liver. It usually occurs in the setting of chronic liver disease and has a poor prognosis if untreated. Orthotopic liver transplantation (OLT) is a suitable therapeutic option for early, unresectable HCC particularly in the setting of chronic liver disease. Following on from disappointing initial results, the seminal study by Mazzaferro et al in 1996 established OLT as a viable treatment for HCC. In this study, the "Milan criteria" were applied achieving a 4-year survival rate similar to OLT for benign disease. Since then various groups have attempted to expand these criteria whilst maintaining long term survival rates. The technique of living donor liver transplantation has evolved over the past decade, particularly in Asia, and published outcome data is comparable to that of OLT. This article will review the evidence, indications, and the future direction of liver transplantation for liver cancer.